Examining the consequences of discontinuing GLP-1 medications on addiction-related hospitalizations
GLP-1 receptor agonists are among the active ingredients in so-called weight-loss injections. Originally developed to treat type 2 diabetes, they are now also used to treat severe obesity. In recent years, studies have provided ...
1 hour ago
0
0









